People: Aquestive Therapeutics Inc (AQST.OQ)
Mr. Keith J. Kendall is President, Chief Executive Officer, Director of the Company since November 2014. After having served as our President and Chief Operating Officer since November 2011, and has served on our board of directors since November 2014. Mr. Kendall also served as our Executive Vice President and Chief Financial Officer beginning in 2006. Mr. Kendall served on the board of directors of Midatech, Pharma Plc (Nasdaq: MTP), from January 2010 to December 2014. From 1999 to 2006, Mr. Kendall served as the Vice President and Managing Director of the Americas for Hewlett Packard Financial Services. Mr. Kendall held a number of positions with AT&T Capital Corporation, including President of AT&T Credit Corporation and NCR Credit Corporation, from 1985 to 1998. Mr. Kendall holds a BS from St. John’s University and an MBA from Pace University.
|Total Annual Compensation, USD||925,000|
|Restricted Stock Award, USD||1,178,670|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||24,769|
|Fiscal Year Total, USD||2,128,440|